<DOC>
	<DOCNO>NCT00003001</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I/II trial study effectiveness combination chemotherapy consist fluorouracil , leucovorin , gemcitabine treat patient recurrent metastatic colorectal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Recurrent Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate survival patient recurrent metastatic colorectal carcinoma treat fluorouracil ( 5-FU ) , leucovorin calcium , gemcitabine . II . Evaluate establish toxic effect profile 5-FU , leucovorin calcium , gemcitabine patient . OUTLINE : This dose escalation study . Patients receive intravenous leucovorin calcium 60 minute bolus infusion fluorouracil ( 5-FU ) , follow gemcitabine infusion , weekly six week follow 2 week rest . The dosage gemcitabine increase few 3 first 6 patient experience grade 3-4 toxicity . Phase II proceeds maximum tolerate dose ( 1 dose level 3 patient experience grade 3-4 toxicity ) . Patients receive minimum two course treatment consider evaluable response . Patients stable disease , partial , complete remission may continue therapy six treatment cycle . Patients exhibit disease progression intolerable toxic effect remove study . PROJECTED ACCRUAL : A total 63 patient accrue .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven recurrent metastatic primary colorectal carcinoma Must measurable disease ( evaluable disease acceptable Phase I ) PATIENT CHARACTERISTICS : Age : Not specify Performance Status : ECOG 03 Life Expectancy : Not specify Hematopoietic : WBC least 3,500/mm3 Platelet count least 150,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL OR 3.0 mg/dL patient liver metastasis Liver enzymes great 3.0 time upper limit normal ( patient liver metastasis ) Renal : Not specify Other : Not pregnant lactate Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior chemotherapy metastatic disease allow Prior treatment 5FU allow Prior treatment irinotecan allow Endocrine therapy : Not specify Radiotherapy : At least 3 week since prior radiotherapy ( measurable disease must locate outside prior radiotherapy portal ) Surgery : Not specify Other : Prior treatment folinic acid allow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2002</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>